Balyasny Asset Management LLC Innoviva, Inc. Transaction History

Balyasny Asset Management LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$14.4 - $16.4 $783,028 - $891,782	-54,377 Reduced 51.24%	51,751 $848,000
Q1 2024 May 13, 2024	BUY	$14.56 - $16.78 $398,114 - $458,815	27,343 Added 34.71%	106,128 $1.62 Million
Q4 2023 Feb 14, 2024	BUY	$12.32 - $16.27 $452,464 - $597,532	36,726 Added 87.32%	78,785 $1.26 Million
Q3 2023 Nov 14, 2023	BUY	$12.37 - $13.89 $188,766 - $211,961	15,260 Added 56.94%	42,059 $546,000
Q2 2023 Aug 14, 2023	BUY	$11.39 - $13.72 $71,267 - $85,846	6,257 Added 30.46%	26,799 $341,000
Q1 2023 May 15, 2023	BUY	$10.73 - $13.6 $220,415 - $279,371	20,542 New	20,542 $231,000
Q3 2022 Nov 14, 2022	BUY	$11.61 - $15.22 $490,301 - $642,755	42,231 New	42,231 $490,000
Q2 2020 Aug 14, 2020	SELL	$11.49 - $15.26 $807,563 - $1.07 Million	-70,284 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$8.11 - $15.23 $16,090 - $30,216	-1,984 Reduced 2.75%	70,284 $827,000
Q4 2019 Feb 14, 2020	BUY	$10.28 - $14.38 $742,915 - $1.04 Million	72,268 New	72,268 $1.02 Million
Q3 2019 Nov 14, 2019	SELL	$10.05 - $14.55 $1.08 Million - $1.56 Million	-107,263 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$13.1 - $14.95 $1.41 Million - $1.6 Million	107,263 New	107,263 $1.56 Million
Q1 2019 May 15, 2019	SELL	$13.69 - $20.06 $429,633 - $629,542	-31,383 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$13.96 - $18.26 $438,106 - $573,053	31,383 New	31,383 $548,000
Q4 2017 Feb 14, 2018	SELL	$11.73 - $14.75 $195,668 - $246,044	-16,681 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$12.06 - $14.12 $201,172 - $235,535	16,681	16,681 $236,000

227

78.9M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.23B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.